Integrum
55.4 SEK -4.15%1 investor is following this company
Integrum is a medical technology company. The company is developing systems for skeletal anchored prostheses based on the developed OPRA implant system, which later are being resold to hospitals worldwide. The implant is placed on the patient's leg with the help of titanium screws and is believed to improve the lives of many patients with amputation. The company was founded in 1998 and is headquartered in Mölndal.
Revenue
74.27M
EBIT %
-26.52 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
INTEG B
Daily low / high price
54 / 57.8
SEK
Market cap
1.02B SEK
Turnover
2.4M SEK
Volume
43K
Financial calendar
Annual report
30.05.2024
Interim report
29.08.2024
General meeting
25.09.2024
Interim report
04.12.2024
Interim report
03.03.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Rickard Brånemark | 31.2 % | 49.6 % |
State Street Bank and Trust | 7.0 % | 5.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Integrum AB: Integrum expands its product offering to the United Kingdom market
Carnegie Commissioned Research: Integrum: CBPR operations suspended
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools